M&T Bank Corporation
1.17xPrice / book
Market cap
$34.26B
Tangible equity (USD)
—
Price / tangible book
—
Price / book
1.17x
Net income / ending equity
9.8%
Net income / ending assets
1.3%
Efficiency ratio
331.5%
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $34.26B · View financials
Snapshot Sep 10, 2026, 11:48 AM ET
Decision snapshot: MTB stock price at discount vs BMRN $237.24 current versus $612.94 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at BMRN's multiple
Implied fair value · at MTB's multiple
Snapshot Sep 10, 2026, 11:48 AM ET
Metric by metric
Filter, sort, and scan the equity metrics that matter most for banks: book value, tangible book, returns, and operating efficiency.
Multiple discount
Lower is better
Profitability edge
Asset efficiency lag
Lower is better
Statements
Reported bank earnings and balances, with each company’s reporting period shown.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
Tangible book and profitability anchor a bank, not enterprise value.
Deposits and cash-like balances distort enterprise value for banks, so this section reads equity value, tangible book and profitability instead.
Price / book
Market cap
$34.26B
Tangible equity (USD)
—
Price / tangible book
—
Price / book
1.17x
Net income / ending equity
9.8%
Net income / ending assets
1.3%
Efficiency ratio
331.5%
Price / tangible book
Market cap
$12.56B
Tangible equity (USD)
$5.68B
Price / tangible book
2.21x
Price / book
2.06x
Net income / ending equity
5.7%
Net income / ending assets
4.6%
Efficiency ratio
—
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
M&T BANK CORPORATION · implied price per share
Bank model off — standard DCF modelling is disabled for financial institutions.
BIOMARIN PHARMACEUTICAL INC · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider banking comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
JPMorgan Chase & Co.
MTB vs JPM
Bank of America Corporation
MTB vs BAC
Wells Fargo & Company
MTB vs WFC
Citigroup Inc.
MTB vs C
PNC FINANCIAL SERVICES GROUP, INC.
MTB vs PNC
VERTEX PHARMACEUTICALS INC / MA
MTB vs VRTX
ALNYLAM PHARMACEUTICALS, INC.
MTB vs ALNY
Sarepta Therapeutics, Inc.
MTB vs SRPT
REGENXBIO Inc.
MTB vs RGNX
IONIS PHARMACEUTICALS INC
MTB vs IONS
PTC THERAPEUTICS, INC.
MTB vs PTCT
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.